|
Volumn 65, Issue 6, 2009, Pages
|
T-cell activation in ischemic stroke: A new therapeutic target for delayed infarct expansion?
a a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
INTERLEUKIN 17;
INTERLEUKIN 1BETA;
INTERLEUKIN 23;
MATRIX METALLOPROTEINASE;
TUMOR NECROSIS FACTOR ALPHA;
BRAIN INFARCTION;
BRAIN INFARCTION SIZE;
BRAIN ISCHEMIA;
BRAIN TUMOR;
BRAIN VASOSPASM;
CELL INFILTRATION;
CEREBROVASCULAR ACCIDENT;
CYTOKINE PRODUCTION;
DISEASE COURSE;
LYMPHOCYTE MIGRATION;
LYMPHOCYTE SUBPOPULATION;
MACROPHAGE;
NONHUMAN;
NOTE;
PRIORITY JOURNAL;
PROTEIN PROTEIN INTERACTION;
T LYMPHOCYTE ACTIVATION;
TREATMENT PLANNING;
ANIMALS;
BRAIN INFARCTION;
CYTOKINES;
DISEASE MODELS, ANIMAL;
IMMUNOSUPPRESSIVE AGENTS;
INFARCTION, MIDDLE CEREBRAL ARTERY;
INTERLEUKIN-17;
INTERLEUKIN-23;
MICE;
MICE, KNOCKOUT;
PROPYLENE GLYCOLS;
SPHINGOSINE;
T-LYMPHOCYTES;
|
EID: 74349091184
PISSN: 0148396X
EISSN: None
Source Type: Journal
DOI: 10.1227/01.NEU.0000345343.04287.23 Document Type: Note |
Times cited : (2)
|
References (10)
|